Structure and Function of Retinol Dehydrogenases of the Short Chain Dehydrogenase/Reductase Family
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Characterization of a Microsomal Retinol Dehydrogenase Gene from Amphioxus: Retinoid Metabolism Before Vertebrates
Chemico-Biological Interactions 130–132 (2001) 359–370 www.elsevier.com/locate/chembiont Characterization of a microsomal retinol dehydrogenase gene from amphioxus: retinoid metabolism before vertebrates Diana Dalfo´, Cristian Can˜estro, Ricard Albalat, Roser Gonza`lez-Duarte * Departament de Gene`tica, Facultat de Biologia, Uni6ersitat de Barcelona, A6. Diagonal, 645, E-08028, Barcelona, Spain Abstract Amphioxus, a member of the subphylum Cephalochordata, is thought to be the closest living relative to vertebrates. Although these animals have a vertebrate-like response to retinoic acid, the pathway of retinoid metabolism remains unknown. Two different enzyme systems — the short chain dehydrogenase/reductases and the cytosolic medium-chain alcohol dehydrogenases (ADHs) — have been postulated in vertebrates. Nevertheless, recent data show that the vertebrate-ADH1 and ADH4 retinol-active forms originated after the divergence of cephalochordates and vertebrates. Moreover, no data has been gathered in support of medium-chain retinol active forms in amphioxus. Then, if the cytosolic ADH system is absent and these animals use retinol, the microsomal retinol dehydrogenases could be involved in retinol oxidation. We have identified the genomic region and cDNA of an amphioxus Rdh gene as a preliminary step for functional characterization. Besides, phyloge- netic analysis supports the ancestral position of amphioxus Rdh in relation to the vertebrate forms. © 2001 Elsevier Science Ireland Ltd. All rights reserved. Keywords: Retinol dehydrogenase; Retinoid metabolism; Amphioxus * Corresponding author. Fax: +34-93-4110969. E-mail address: [email protected] (R. Gonza`lez-Duarte). 0009-2797/01/$ - see front matter © 2001 Elsevier Science Ireland Ltd. All rights reserved. PII: S0009-2797(00)00261-1 360 D. -
Methionine Sulfoxide Reductase a Is a Stereospecific Methionine Oxidase
Methionine sulfoxide reductase A is a stereospecific methionine oxidase Jung Chae Lim, Zheng You, Geumsoo Kim, and Rodney L. Levine1 Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-8012 Edited by Irwin Fridovich, Duke University Medical Center, Durham, NC, and approved May 10, 2011 (received for review February 10, 2011) Methionine sulfoxide reductase A (MsrA) catalyzes the reduction Results of methionine sulfoxide to methionine and is specific for the S epi- Stoichiometry. Branlant and coworkers have studied in careful mer of methionine sulfoxide. The enzyme participates in defense detail the mechanism of the MsrA reaction in bacteria (17, 18). against oxidative stresses by reducing methionine sulfoxide resi- In the absence of reducing agents, each molecule of MsrA dues in proteins back to methionine. Because oxidation of methio- reduces two molecules of MetO. Reduction of the first MetO nine residues is reversible, this covalent modification could also generates a sulfenic acid at the active site cysteine, and it is function as a mechanism for cellular regulation, provided there reduced back to the thiol by a fast reaction, which generates a exists a stereospecific methionine oxidase. We show that MsrA disulfide bond in the resolving domain of the protein. The second itself is a stereospecific methionine oxidase, producing S-methio- MetO is then reduced and again generates a sulfenic acid at the nine sulfoxide as its product. MsrA catalyzes its own autooxidation active site. Because the resolving domain cysteines have already as well as oxidation of free methionine and methionine residues formed a disulfide, no further reaction forms. -
Supplementary Materials
1 Supplementary Materials: Supplemental Figure 1. Gene expression profiles of kidneys in the Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice. (A) A heat map of microarray data show the genes that significantly changed up to 2 fold compared between Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice (N=4 mice per group; p<0.05). Data show in log2 (sample/wild-type). 2 Supplemental Figure 2. Sting signaling is essential for immuno-phenotypes of the Fcgr2b-/-lupus mice. (A-C) Flow cytometry analysis of splenocytes isolated from wild-type, Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice at the age of 6-7 months (N= 13-14 per group). Data shown in the percentage of (A) CD4+ ICOS+ cells, (B) B220+ I-Ab+ cells and (C) CD138+ cells. Data show as mean ± SEM (*p < 0.05, **p<0.01 and ***p<0.001). 3 Supplemental Figure 3. Phenotypes of Sting activated dendritic cells. (A) Representative of western blot analysis from immunoprecipitation with Sting of Fcgr2b-/- mice (N= 4). The band was shown in STING protein of activated BMDC with DMXAA at 0, 3 and 6 hr. and phosphorylation of STING at Ser357. (B) Mass spectra of phosphorylation of STING at Ser357 of activated BMDC from Fcgr2b-/- mice after stimulated with DMXAA for 3 hour and followed by immunoprecipitation with STING. (C) Sting-activated BMDC were co-cultured with LYN inhibitor PP2 and analyzed by flow cytometry, which showed the mean fluorescence intensity (MFI) of IAb expressing DC (N = 3 mice per group). 4 Supplemental Table 1. Lists of up and down of regulated proteins Accession No. -
Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen, -
Serum Albumin OS=Homo Sapiens
Protein Name Cluster of Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 (P14136) Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 Cluster of Isoform 3 of Plectin OS=Homo sapiens GN=PLEC (Q15149-3) Cluster of Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 (P68871) Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 Cluster of Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 (Q13509) Cluster of Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 (P60709) Cluster of Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1 (P68363) Cluster of Isoform 2 of Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1 (Q13813-2) Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 Cluster of Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 (Q01082) Cluster of Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM PE=1 SV=4 (P14618) Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5 Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 Cluster of ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide OS=Homo sapiens GN=ATP1A2 PE=3 SV=1 (B1AKY9) Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 Cluster of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 (P12814) 60 kDa heat shock protein, mitochondrial OS=Homo -
(12) United States Patent (10) Patent No.: US 8,048,918 B2 Ward Et Al
USOO8048918B2 (12) United States Patent (10) Patent No.: US 8,048,918 B2 Ward et al. (45) Date of Patent: Nov. 1, 2011 (54) TREATMENT OF HYPERPROLIFERATIVE FOREIGN PATENT DOCUMENTS DISEASES EP 0284.879 A2 10, 1988 EP O610511 8, 1994 GB 2023001. A * 12, 1979 (75) Inventors: Simon Ward, Sheffield (GB); Claes WO WO 97.15298 5, 1999 Bavik, Sheffield (GB); Michael Cork, WO WOO1/30383 5, 2001 Sheffield (GB); Rachid Tazi-Aahnini, WO WO O2/OO2O74 1, 2002 Sheffield (GB) WO WO O2/O72084 9, 2002 (73) Assignee: Vampex Limited, Manchester (GB) OTHER PUBLICATIONS NapoliJL. “Retinol Metabolism in LLC-PK1 Cells. Characterization (*) Notice: Subject to any disclaimer, the term of this of Retinoic Acid Synthesis by an Established Mammalian Cell Line.” patent is extended or adjusted under 35 Journal of Biological Chemistry, 1986:261 (29): 13592-13597.* “Glucocorticoid”. Stedman's Medical Dictionary (Twenty-Second U.S.C. 154(b) by 385 days. Edition). The Williams and Wilkins Company, 1972. p. 527.* Ghosh et al. “Mechanism of Inhibition of 3alpha,20beta (21) Appl. No.: 10/085,239 hydroxysteroid Dehydrogenase by a Licorice-Derived Steroidal Inhibitor”. Structure, Oct. 15, 1994; 2(10):973-980.* (22) Filed: Feb. 27, 2002 Kelloff et al. “Chemopreventive Drug Development: Perspectives and Progress”. Cancer Epidemiology, Biomarkers and Prevention. 3. (65) Prior Publication Data 1994:85-98.* Bavik, Claes et al., “Retinol-Binding Protein Mediates Uptake of US 2003/O1197.15A1 Jun. 26, 2003 Retinol to Cultured Human Keratinocytes'. Exp. Cell Res., vol. 216, pp. 358-62 (1996). Melhus, Hakan et al., “Epitope Mapping of a Monoclonal Antibody Related U.S. -
Supplementary Materials
Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented. -
Chemistry of a Dehydrogenase and Di-Heme Enzyme Related to Tryptophan Oxidation
Georgia State University ScholarWorks @ Georgia State University Chemistry Dissertations Department of Chemistry 8-10-2021 Chemistry of a Dehydrogenase and Di-heme Enzyme Related to Tryptophan Oxidation Christopher Ian Davis Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_diss Recommended Citation Davis, Christopher Ian, "Chemistry of a Dehydrogenase and Di-heme Enzyme Related to Tryptophan Oxidation." Dissertation, Georgia State University, 2021. https://scholarworks.gsu.edu/chemistry_diss/201 This Dissertation is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Chemistry Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. CHEMISTRY OF A DEHYDROGENASE AND DI-HEME ENZYME RELATED TO TRYPTOPHAN OXIDATION by CHRISTOPHER IAN DAVIS Under the Direction of Aimin Liu PhD ABSTRACT Tryptophan is an essential amino acid that is used as a building block to construct proteins, the biosynthetic precursor for several essential molecules, and is modified to serve as a cofactor in some enzymes. This dissertation focuses on two enzymes involved in tryptophan oxidation, AMSDH and MauG. AMSDH is a dehydrogenase in the kynurenine pathway, which is the main metabolic route for tryptophan catabolism. In addition to breaking down tryptophan, the kynurenine pathway is also involved in regulating the innate immune response, NAD biosynthesis, and some neurodegenerative. As such, enzymes of the kynurenine pathway are of fundamental interest for study. This work leveraged a bacterial homologue of human AMSDH to solve its crystal structure in various forms, including several catalytic intermediates. -
Key Enzymes of the Retinoid (Visual) Cycle in Vertebrate Retina☆
Biochimica et Biophysica Acta 1821 (2012) 137–151 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbalip Review Key enzymes of the retinoid (visual) cycle in vertebrate retina☆ Philip D. Kiser a,1, Marcin Golczak a,1, Akiko Maeda a,b,⁎, Krzysztof Palczewski a,⁎⁎ a Department of Pharmacology, Case Western Reserve University, Cleveland, OH, 44106-4965, USA b Department of Ophthalmology and Vision Sciences, Case Western Reserve University, Cleveland, OH, 44106-4965, USA article info abstract Article history: A major goal in vision research over the past few decades has been to understand the molecular details of Received 19 January 2011 retinoid processing within the retinoid (visual) cycle. This includes the consequences of side reactions that Received in revised form 8 March 2011 result from delayed all-trans-retinal clearance and condensation with phospholipids that characterize a Accepted 22 March 2011 variety of serious retinal diseases. Knowledge of the basic retinoid biochemistry involved in these diseases is Available online 5 April 2011 essential for development of effective therapeutics. Photoisomerization of the 11-cis-retinal chromophore of rhodopsin triggers a complex set of metabolic transformations collectively termed phototransduction that Keywords: RPE65 ultimately lead to light perception. Continuity of vision depends on continuous conversion of all-trans-retinal Retinol dehydrogenase back to the 11-cis-retinal isomer. This process takes place in a series of reactions known as the retinoid cycle, Visual cycle which occur in photoreceptor and RPE cells. All-trans-retinal, the initial substrate of this cycle, is a chemically Retinoid cycle reactive aldehyde that can form toxic conjugates with proteins and lipids. -
A Brief Guide to Enzyme Classification and Nomenclature Rev AM
A Brief Guide to Enzyme Nomenclature and Classification Keith Tipton and Andrew McDonald 1) Introduction NC-IUBMB Enzyme List, or, to give it its full title, “Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes by the Reactions they Catalyse,1 is a functional system, based solely on the substrates transformed and products formed by an enzyme. The basic layout of the classification for each enzyme is described below with some indication of the guidelines followed. More detailed rules for enzyme nomenclature and classification are available online.2 Further details of the principles governing the nomenclature of individual enzyme classes are given in the following sections. 2. Basic Concepts 2.1. EC numbers Enzymes are identified by EC (Enzyme Commission) numbers. These are also valuable for relating the information to other databases. They were divided into 6 major classes according to the type of reaction catalysed and a seventh, the translocases, was added in 2018.3 These are shown in Table 1. Table 1. Enzyme classes Name Reaction catalysed 1 Oxidoreductases *AH2 + B = A +BH2 2 Transferases AX + B = BX + A 3 Hydrolases A-B + H2O = AH + BOH 4 Lyases A=B + X-Y = A-B ç ç X Y 5 Isomerases A = B 6 LiGases †A + B + NTP = A-B + NDP + P (or NMP + PP) 7 Translocases AX + B çç = A + X + ççB (side 1) (side 2) *Where nicotinamide-adenine dinucleotides are the acceptors, NAD+ and NADH + H+ are used, by convention. †NTP = nucleoside triphosphate. The EC number is made up of four components separated by full stops. -
Protein Network Analyses of Pulmonary Endothelial Cells In
www.nature.com/scientificreports OPEN Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension Sarath Babu Nukala1,8,9*, Olga Tura‑Ceide3,4,5,9, Giancarlo Aldini1, Valérie F. E. D. Smolders2,3, Isabel Blanco3,4, Victor I. Peinado3,4, Manuel Castell6, Joan Albert Barber3,4, Alessandra Altomare1, Giovanna Baron1, Marina Carini1, Marta Cascante2,7,9 & Alfonsina D’Amato1,9* Chronic thromboembolic pulmonary hypertension (CTEPH) is a vascular disease characterized by the presence of organized thromboembolic material in pulmonary arteries leading to increased vascular resistance, heart failure and death. Dysfunction of endothelial cells is involved in CTEPH. The present study describes for the frst time the molecular processes underlying endothelial dysfunction in the development of the CTEPH. The advanced analytical approach and the protein network analyses of patient derived CTEPH endothelial cells allowed the quantitation of 3258 proteins. The 673 diferentially regulated proteins were associated with functional and disease protein network modules. The protein network analyses resulted in the characterization of dysregulated pathways associated with endothelial dysfunction, such as mitochondrial dysfunction, oxidative phosphorylation, sirtuin signaling, infammatory response, oxidative stress and fatty acid metabolism related pathways. In addition, the quantifcation of advanced oxidation protein products, total protein carbonyl content, and intracellular reactive oxygen species resulted increased -
Characterization of Cd36 03230P, a Putative Vanillin Dehydrogenase from Candida Dubliniensis† Cite This: RSC Adv.,2016,6, 99774 Suprama Datta,Ab Uday S
RSC Advances View Article Online COMMUNICATION View Journal | View Issue Characterization of Cd36_03230p, a putative vanillin dehydrogenase from Candida dubliniensis† Cite this: RSC Adv.,2016,6, 99774 Suprama Datta,ab Uday S. Annapureb and David J. Timson*ac Received 5th September 2016 Accepted 10th October 2016 DOI: 10.1039/c6ra22209a www.rsc.org/advances A coding sequence (CD36-03230) from the yeast Candida dubliniensis derived phenylpropanoids (such as vanillin, vanillate, caffeate, p- had been previously annotated as a vanillin dehydrogenase (VDH). The coumarate, cinnamate and benzaldehyde). These aromatic alde- corresponding protein (CD36-03230p) was recombinantly expressed hydes, especially vanillin, are abundant as avour and aromas in in Escherichia coli and analysed. The protein is most likely a tetramer in food and cosmetic industries. It is important to elucidate the Creative Commons Attribution 3.0 Unported Licence. solution as judged by crosslinking and gel filtration experiments. structural and functional characteristics of these enzymes given CD36-03230p is an active aldehyde dehydrogenase favouring cyclic their potential role in food chemistry and biotechnology. This and aromatic substrates. Positive cooperativity and substrate inhibition group of enzymes has been characterized in a number of eubac- were observed with some substrates. The redox cofactor NADP+ and terial species, including Pseudomonas uorescens,6 Pseudomonas substrates affected the thermal stability of the protein. Interestingly, putida KT2440,13 Corynebacterium